Advertisement

Advertisement

GOSS Stock Latest News

Gossamer Bio Defendants Move to Dismiss Securities Lawsuit Over PROSERA Trial Disclosures

Class ActionGossamer Bio Defendants Move to Dismiss Securities Lawsuit Over PROSERA Trial Disclosures

Gossamer Bio Adds Veteran Investor to Board of Directors

PremiumCompany Announcements

Gossamer Bio Adds Veteran Investor to Board of Directors

3d ago

Gossamer Bio Executes Reverse Stock Split and Share Reduction

PremiumCompany Announcements

Gossamer Bio Executes Reverse Stock Split and Share Reduction

8d ago

Gossamer Bio announces effectiveness of 1-for-80 reverse stock split

PremiumThe Fly

Gossamer Bio announces effectiveness of 1-for-80 reverse stock split

9d ago

Gossamer Bio trading halted, news pending

PremiumThe Fly

Gossamer Bio trading halted, news pending

9d ago

Gossamer Bio Announces 1-for-80 Reverse Stock Split

PremiumCompany AnnouncementsGossamer Bio Announces 1-for-80 Reverse Stock Split

10d ago

Gossamer Bio announces 1-for-80 reverse stock split

The Fly

Gossamer Bio announces 1-for-80 reverse stock split

10d ago

Gossamer Bio Lowers Stockholder Meeting Quorum Requirement

Company Announcements

Gossamer Bio Lowers Stockholder Meeting Quorum Requirement

16d ago

Gossamer Bio Amends Charter for New Preferred Financing

PremiumCompany Announcements

Gossamer Bio Amends Charter for New Preferred Financing

24d ago

Gossamer Bio Secures Major Seralutinib Regulatory Financing Deal

PremiumCompany Announcements

Gossamer Bio Secures Major Seralutinib Regulatory Financing Deal

30d ago

Gossamer Bio announces upt to $250M structured private placement

PremiumThe Fly

Gossamer Bio announces upt to $250M structured private placement

30d ago

Gossamer Bio reports Q2 EPS (8c), consensus (12c)

PremiumThe Fly

Gossamer Bio reports Q2 EPS (8c), consensus (12c)

1M ago

Gossamer Bio price target lowered to $4 from $15 at Piper Sandler

PremiumThe FlyGossamer Bio price target lowered to $4 from $15 at Piper Sandler

1M ago

GOSS Earnings this Week: How Will it Perform?

Pre-Earnings

GOSS Earnings this Week: How Will it Perform?

1M ago

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

Weekend Updates

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

2M ago

Gossamer Bio upgraded to Outperform from Market Perform at Leerink

PremiumThe Fly

Gossamer Bio upgraded to Outperform from Market Perform at Leerink

2M ago

Gossamer Bio Reclaims Seralutinib Rights and Control

PremiumCompany Announcements

Gossamer Bio Reclaims Seralutinib Rights and Control

2M ago

Morning Movers: Ensign Group surges following second quarter results

PremiumThe Fly

Morning Movers: Ensign Group surges following second quarter results

2M ago

Gossamer announces FDA regulatory update, reacquisition of Seralutinib rights

PremiumThe Fly

Gossamer announces FDA regulatory update, reacquisition of Seralutinib rights

2M ago

Gossamer Bio Sets Conversion Terms for Convertible Notes

PremiumCompany AnnouncementsGossamer Bio Sets Conversion Terms for Convertible Notes

3M ago

Gossamer Bio announces determination of conversion rate for senior secured notes

The Fly

Gossamer Bio announces determination of conversion rate for senior secured notes

3M ago

Gossamer Bio price target lowered to $2 from $5 at H.C. Wainwright

The Fly

Gossamer Bio price target lowered to $2 from $5 at H.C. Wainwright

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >